Copyright © 2021 · All Rights Reserved · UK ATTR Amyloidosis Patients Association
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Diagnosis and Treatment
All patients with suspected or diagnosed ATTR amyloidosis should be assessed in a dedicated specialist unit. In the UK, the referral centre is the NHS National Amyloidosis Centre (NAC) at the Royal Free Hospital, London. Information for referring physicians in the UK is available here.
The Centre for Amyloidosis and Acute Phase Proteins comprises the NHS National Amyloidosis Centre, funded since 1999 by the Department of Health to provide diagnostic and management advisory services for the national caseload of patients with amyloidosis, and the Wolfson Drug Discovery Unit.
Doctors may suspect ATTR amyloidosis on the basis of patients’ symptoms, findings on physical examination and sometimes family history. The diagnosis can be confirmed (or eliminated) by tests including:
More on Diagnosis
Treatment
Treatment of all types of amyloidosis is currently based on the following principles:
When amyloid precursor protein supply is controlled:
More on Treatment
Coronavirus Update
Information about COVID-19 (corona) for patients with ATTR amyloidosis is available on the National Amyloidosis Centre website – see here.